Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database

• DOI: 10.1016/j.heliyon.2024.e34837
• Publication Date: 2024-07-18T01:37:23Z
• Authors: Jinfeng Zhu; Mianda Hu; Yingshi Liang; Mingjun Zhong; Zilin Chen; Zhenjie Wang; Yujia Yang; Ziyi Luo; Wenqi Zeng; Jiahui Li; Yikuan Du; Yi Liu; Chun Yang
• Keywords: Orlistat

Based on the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS) database, we analyzed signals of potential adverse events (AEs) orlistat in real world to provide a reference for its safe clinical use.